Currently out of the existing stock ratings of Laura Chico, 206 are a BUY (66.88%), 100 are a HOLD (32.47%), 2 are a SELL (0.65%).

Laura Chico

Work Performance Price Targets & Ratings Chart

Analyst Laura Chico, currently employed at WEDBUSH, carries an average stock price target met ratio of 48.56% that have a potential upside of 35.74% achieved within 177 days.

Laura Chico’s has documented 624 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GOSS, Gossamer Bio at 14-Mar-2025.

Wall Street Analyst Laura Chico

Analyst best performing recommendations are on DNLI (DENALI THERAPEUTICS).
The best stock recommendation documented was for DNLI (DENALI THERAPEUTICS) at 11/10/2020. The price target of $64 was fulfilled within 1 day with a profit of $4 (6.67%) receiving and performance score of 66.67.

Average potential price target upside

ACER Acer Therapeutics ALXN Alexion Pharmaceuticals APLS Apellis Pharmaceuticals APTX Aptinyx ARDX Ardelyx BHVN Biohaven Pharmaceutical Holding Co Ltd BIIB Biogen DNLI Denali Therapeutics KRTX Karuna Therapeutics NBIX Neurocrine Biosciences PRAX Praxis Precision Medicines  RARE Ultragenyx RTRX Travere Therapeutics SAGE Sage Therapeutic TSHA Taysha Gene Therapies  TVTX Travere Therapeutics VIE Viela Bio XENE Xenon Pharmaceuticals PRVL Prevail Therapeutics VYGR Voyager Therapeutics DSGN Design Therapeutics IMPL Impel Neuropharma VERA Vera Therapeutics STOK Stoke Therapeutics DOVA Dova Pharmaceuticals MLND Millendo Therapeutics PEPG PepGen Ltd VIGL Vigil Neuroscience VRTX Vertex Pharmaceuticals ATXS Astria Therapeutics PASG Passage Bio BMRN Biomarin Pharmaceutical EWTX Edgewise Therapeutics KDNY Chinook Therapeutics LBPH Longboard Pharmaceuticals PHVS Pharvaris BV RLYB Rallybio Corp VRDN Viridian Therapeutics AVTE Aerovate Therapeutics GOSS Gossamer Bio

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.5

$0.84 (127.27%)

$10

1 years 6 months 29 days ago
(01-Sep-2023)

0/3 (0%)

$0.36 (31.58%)

Buy

$8

$7.34 (1112.12%)

$9

3 years 23 days ago
(07-Mar-2022)

0/2 (0%)

$5.54 (225.20%)

Buy

$8

$7.34 (1112.12%)

$48

5 years 9 months 5 days ago
(25-Jun-2019)

0/4 (0%)

$3.88 (94.17%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Laura Chico is most bullish on?

Potential upside of $33.84 has been obtained for NBIX (NEUROCRINE BIOSCIENCES)

Which stock is Laura Chico is most reserved on?

Potential downside of -$2.28 has been obtained for SAGE (SAGE THERAPEUTIC)

What Year was the first public recommendation made by Laura Chico?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?